Fifty healthcare advocacy organizations have signed onto a letter urging Congress to include incentives for the development of new antibiotics and companion diagnostics in the Prescription Drug User Fee Act,…

Is the medical device industry’s political and regulatory agenda at odds with the needs of patients? That’s one of the questions explored in an article published late last week by…

It can be challenging for independent investigators to access all of the training they need to participate in clinical trials. Mayo Medical Laboratories offers an online course that may help…

NIH will host its fifth annual Rare Disease Day on February 29, 2012. FDA’s Rare Disease Patient Advocacy Day is set for March 1st. The purpose of both events is…

In an column published last week by the Fiscal Times, Merrill Goozner questions the $4-12B per-approved-drug price tag proposed recently by Forbes columnist Matthew Herper. Goozner, who has written a book on…